Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Targeting regulatory T cells may help treat age-related diseases.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Clonally expanded CD8+ T cells cause alopecia areata.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

γδ T cells are essential for wound healing after poxvirus infection.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Potential therapeutic targets for scarring hair loss are identified.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.